Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Twist Bioscience Corp (TWST)

Healthcare Diagnostics & Research
91.60 $
+0.2% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Twist Bioscience Corp (TWST)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 88.9% of the shares are freely tradable; institutional investors hold 123.8%.

Ownership Structure

Institutional ownership
123.8%
Insiders
1.3%
Float
88.9%
Short % of float
36.4%
Shares Outstanding
62Mio.

Largest Shareholders

Institutions

Institutions TWST
Name Stake (%) Shares Change (%) Date
Artisan Partners Limited Partnership 10.23 6,367,777 +9.2 03/31/2026
ARK Investment Management LLC 10.19 6,342,733 -16.1 03/31/2026
Vanguard Group Inc 9.28 5,776,198 +0.1 12/31/2025
BlackRock Inc 8.92 5,554,362 -5.8 03/31/2026
EdgePoint Investment 8.64 5,382,521 +0.1 03/31/2026
William Blair Investment Management, LLC 8.46 5,269,718 -11.5 03/31/2026
State Street Corp 5.89 3,670,682 +1.2 03/31/2026
Vanguard Portfolio Management, LLC 4.25 2,649,101 +0.0 03/31/2026

Funds

Funds TWST
Name Stake (%) Shares Change (%) Date
ARK Disruptive Innovation Full Composite 5.70 3,552,537 -19.6 03/31/2026
ARK Innovation ETF 5.23 3,255,254 +2.3 05/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
23. Jul 2026 Finn Patrick John President and COO Sell 2,238 93.89 210,133
9. Jul 2026 Laponis Adam Chief Financial Officer Sell 2,399 94.33 226,307
22. Apr 2026 Emily M Leproust CEO Sell 8,061 65.29 526,303
21. Apr 2026 Emily M Leproust CEO Sell 1,610 65.01 104,666
17. Apr 2026 Adam Laponis CFO Sell 4,000 60.00 240,000

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?